Jerry McMahon is the founder of Storm Therapeutics. Storm Therapeutics has raised $126M in total funding. Latest round: Series C.
Jerry McMahon is the President and CEO of Storm Therapeutics, a biotechnology company focused on modifying RNA with small molecules to treat cancers and other diseases. He announced a $56 million Series C financing round in 2024 to advance STC-15, an oral METTL3 inhibitor currently in Phase 2 trials for sarcoma indications.
Full founder directory · Investor directory · Company funding database · Fundraising library